{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:47:24Z","timestamp":1791229644697,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001834","name":"University of Twente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jconrel.2020.09.041","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T12:25:35Z","timestamp":1600950335000},"page":"640-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo"],"prefix":"10.1016","volume":"328","author":[{"given":"Dhadhang Wahyu","family":"Kurniawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richell","family":"Booijink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-2462","authenticated-orcid":false,"given":"Lena","family":"Pater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Wols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggelos","family":"Vrynas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2470-5876","authenticated-orcid":false,"given":"Ruchi","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.09.041_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0015","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0020","doi-asserted-by":"crossref","first-page":"7629724","DOI":"10.1155\/2016\/7629724","article-title":"Clinical advancements in the targeted therapies against liver fibrosis","volume":"2016","author":"Bansal","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0025","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2017.07.010","article-title":"Drug targeting to myofibroblasts: implications for fibrosis and cancer","volume":"121","author":"Yazdani","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0045","doi-asserted-by":"crossref","first-page":"8323747","DOI":"10.1155\/2016\/8323747","article-title":"Regulation of hepatic stellate cells and Fibrogenesis by fibroblast growth factors","volume":"2016","author":"Schumacher","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.gendis.2014.09.005","article-title":"Fibroblast growth factor (FGF) signaling in development and skeletal diseases","volume":"1","author":"Teven","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11248-012-9636-9","article-title":"Fibroblast growth factor (Fgf) signaling pathway regulates liver homeostasis in zebrafish","volume":"22","author":"Tsai","year":"2013","journal-title":"Transgenic Res."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0060","first-page":"26","article-title":"Biological roles of fibroblast growth factor-2","volume":"18","author":"Bikfalvi","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2017.09.003","article-title":"Fibroblast growth factor 2 as an Antifibrotic: antagonism of Myofibroblast differentiation and suppression of pro-fibrotic gene expression","volume":"38","author":"Dolivo","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0070","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0002-9440(10)63522-5","article-title":"Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis","volume":"163","author":"Yu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0075","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.27649","article-title":"Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1","volume":"61","author":"Pan","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.5106","article-title":"Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation","volume":"246","author":"Koo","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fcell.2020.00147","article-title":"Fibroblast growth factor 2 attenuates renal ischemia-reperfusion injury via inhibition of endoplasmic reticulum stress","volume":"8","author":"Tan","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","article-title":"Structural basis for FGF receptor dimerization and activation","volume":"98","author":"Plotnikov","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0095","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.274.49.34785","article-title":"Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity","volume":"274","author":"Chellaiah","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0092-8674(00)80851-X","article-title":"Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity","volume":"101","author":"Plotnikov","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0105","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/0016-5085(95)90767-X","article-title":"Fibroblast growth factor 2 and transforming growth factor b1 interactions in human liver myofibroblast","volume":"109","author":"Rosenbaum","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/00912700122010230","article-title":"Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease","volume":"41","author":"Bush","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.nano.2011.08.017","article-title":"Iron oxide nanoparticles for targeted cancer imaging and diagnostics","volume":"8","author":"Rosen","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1021\/ar200084x","article-title":"Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy","volume":"44","author":"Tassa","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nano.2018.12.008","article-title":"Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis","volume":"17","author":"Nagorniewicz","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0130","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/hep.21622","article-title":"Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma","volume":"45","author":"Wurmbach","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7150\/ntno.38092","article-title":"FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor","volume":"4","author":"Mardhian","year":"2020","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215549704500710","article-title":"Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues","volume":"45","author":"Hughes","year":"1997","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01213308","article-title":"Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease","volume":"32","author":"Jim-No","year":"1997","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0150","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41598-020-61510-4","article-title":"Fibroblast growth factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma","volume":"10","author":"Seitz","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0155","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cbin.10588","article-title":"FGF2 regulates proliferation, migration, and invasion of ECA109 cells through PI3K\/Akt signalling pathway in vitro","volume":"40","author":"Shi","year":"2016","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0160","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1038\/srep03470","article-title":"HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis","volume":"3","author":"Son","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0165","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0170","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/jps.22054","article-title":"Delivery of therapeutic proteins","volume":"99","author":"Pisal","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.09.031","article-title":"Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo","volume":"290","author":"Mardhian","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0180","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.M117.793794","article-title":"Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling","volume":"292","author":"Sato-Matsubara","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1748-0132(07)70084-1","article-title":"Magnetic nanoparticles for drug delivery","volume":"2","author":"Arruebo","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2015.08.022","article-title":"Magnetic nanoparticle-based drug delivery for cancer therapy","volume":"468","author":"Tietze","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2020.09.041_bb0200","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1242\/dev.152587","article-title":"Fibroblast growth factors: key players in regeneration and tissue repair","volume":"144","author":"Maddaluno","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.jconrel.2020.09.041_bb0205","doi-asserted-by":"crossref","first-page":"218142","DOI":"10.4061\/2010\/218142","article-title":"Fibroblast growth factors: biology, function, and application for tissue regeneration","volume":"2010","author":"Yun","year":"2010","journal-title":"J. Tissue Eng."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920305575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920305575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:21:13Z","timestamp":1718421673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920305575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":40,"alternative-id":["S0168365920305575"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}